Vietnam Controlled Release Drug Delivery Market to Grow with a CAGR of 8.65% through 2030
Advancements in biotechnology and
the increasing adoption of personalized medicine is expected to drive the
Vietnam Controlled Release Drug Delivery Market growth in the forecast period, 2026-2030.
According to TechSci Research report, “Vietnam Controlled
Release Drug Delivery Market –– By Region, Competition, Forecast and
Opportunities, 2030F”, the Vietnam Controlled Release Drug Delivery Market stood
at USD 276.32
Million in 2024 and is expected to reach USD 455.63 Million by 2030 with a CAGR
of 8.65% during the forecast period.
The Vietnam
Controlled Release Drug Delivery Market is witnessing substantial growth driven
by the increasing prevalence of chronic diseases, advancements in
pharmaceutical technology, and a rising demand for more convenient and
effective drug therapies. Controlled release drug delivery systems (CRDDS)
offer the advantage of providing a consistent and prolonged release of
medication, reducing the frequency of dosing and improving patient adherence to
treatment regimens. As the Vietnamese population grapples with a growing burden
of chronic conditions such as diabetes, hypertension, cardiovascular diseases,
and cancer, the demand for these innovative systems is becoming more
pronounced. The market is benefiting from the increasing recognition of the
importance of patient compliance, which is critical in the management of
long-term conditions that require continuous medication.
In the urban
areas, particularly in Southern Vietnam, the demand for controlled release drug
systems is significantly higher due to a better-developed healthcare
infrastructure, improved awareness about chronic disease management, and higher
disposable incomes. Ho Chi Minh City, the largest economic hub in the country,
plays a central role in this development. Southern Vietnam also houses the
majority of pharmaceutical companies, both domestic and international, who are
actively introducing and distributing controlled release formulations. These
systems are seen as a viable solution to manage the growing number of patients
with chronic diseases in urban settings. Patients in these areas are more
likely to seek treatments that not only improve their health outcomes but also
offer the convenience of fewer doses, reducing the inconvenience of managing
daily medications. This is especially relevant for patients dealing with
complex therapeutic regimens that would otherwise require multiple doses a day.
In addition, the
prevalence of middle and upper-income consumers in Southern Vietnam has made
the region an attractive market for premium pharmaceutical products, including
controlled release systems, which are generally more expensive than traditional
drug delivery methods. As these consumers become more health-conscious and seek
higher-quality treatments, the market for controlled release drug delivery
systems is expanding. Pharmaceutical companies, recognizing the potential in
this growing market, are increasingly focusing on developing products that
cater to these needs. They are also investing in research and development to
improve the performance, cost-efficiency, and accessibility of controlled
release formulations.
Northern
Vietnam, with Hanoi as its major metropolitan area, is also contributing to the
growth of the controlled release drug delivery market. Although the region’s
healthcare infrastructure and economic development are not as advanced as
Southern Vietnam, Northern Vietnam is seeing gradual improvements. The local
government has been making concerted efforts to enhance the healthcare system
and attract investments in the pharmaceutical sector. These efforts are slowly
leading to better access to innovative drug delivery systems in major cities.
However, the penetration of controlled release drug delivery systems in rural
areas remains limited due to cost barriers, lack of awareness, and a preference
for conventional drug formulations.
Meanwhile,
Central Vietnam faces several challenges that hinder the widespread adoption of
controlled release systems. The region, including cities like Da Nang, is less
economically developed than both the north and the south, with limited
healthcare infrastructure and fewer healthcare professionals specializing in
advanced drug delivery systems. While the government has made strides in
improving healthcare access, the region still lags in terms of awareness and
demand for innovative drug therapies. The use of controlled release drug
delivery systems in Central Vietnam is primarily concentrated in urban centers,
where healthcare facilities are more advanced and more patients are able to
afford such treatments.
Despite these
regional disparities, the controlled release drug delivery market in Vietnam is
generally characterized by an increasing shift toward more sophisticated and
patient-friendly medication regimens. Patients in both urban and rural areas
are beginning to recognize the benefits of controlled release systems, such as
reduced dosing frequency, improved therapeutic efficacy, and enhanced
convenience. However, the market faces challenges related to the affordability
of these advanced therapies, particularly for lower-income populations who
still rely on traditional drug delivery methods. As a result, pharmaceutical
companies are focusing on making controlled release systems more accessible and
affordable to a broader segment of the population, including through
partnerships with local healthcare providers and governmental initiatives aimed
at reducing drug costs.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Vietnam Controlled Release Drug Delivery Market”
The Vietnam Controlled Release Drug Delivery Market is
segmented into technology, release mechanism, delivery application, regional
distribution, and company.
Based on delivery application, Oral Controlled-Drug
Delivery Systems are currently the dominant method. Oral controlled drug
delivery systems, which include formulations such as tablets and capsules
designed to release active ingredients in a controlled manner over a period of
time, have become the preferred option due to their convenience, ease of
administration, and cost-effectiveness. This dominance is particularly
noticeable in Vietnam, where oral drug formulations are the most common method
of medication delivery due to their widespread acceptance and accessibility.
The increasing prevalence of chronic diseases such as
diabetes, hypertension, and cardiovascular conditions in Vietnam has created a
large market for oral controlled release systems. These systems are highly
effective in managing long-term conditions by providing sustained therapeutic
effects while reducing the need for multiple daily doses. The controlled
release feature of oral formulations ensures that patients maintain consistent
drug levels in their bloodstream, improving the efficacy of the medication and
enhancing patient compliance. Given the significant burden of chronic diseases
in Vietnam, the demand for oral controlled release systems is expected to
continue growing, as these formulations offer a practical solution for managing
ongoing health conditions.
Based on region, Northern Vietnam is currently the
dominant region in the Vietnam controlled release drug delivery market,
primarily due to its economic development, increasing healthcare investments,
and rising demand for innovative drug delivery systems in the region. Hanoi,
the capital city, plays a central role in driving healthcare advancements in
Northern Vietnam. As one of the largest urban areas in the country, Hanoi has
seen significant improvements in its healthcare infrastructure, including the introduction
of modern medical technologies and more advanced pharmaceutical solutions, such
as controlled release drug delivery systems. The growing awareness of chronic
diseases, including diabetes, cardiovascular conditions, and hypertension, has
further fueled the demand for controlled release formulations, which are seen
as a convenient solution for managing long-term illnesses that require
sustained medication.
In recent years, the Vietnamese government has been
making concerted efforts to improve healthcare access and quality in the
northern region. Investment in healthcare infrastructure, including the
establishment of new hospitals and clinics equipped with advanced medical
technologies, has contributed to the adoption of modern drug delivery systems.
As a result, the demand for controlled release drugs has surged in Northern
Vietnam, with more healthcare providers looking to incorporate innovative drug
delivery technologies into their treatment options. The region is also home to
a growing number of pharmaceutical companies that are investing in research and
development (R&D) to improve the availability of controlled release
formulations tailored to the needs of patients with chronic diseases. These
companies are not only expanding their product offerings but are also working
on enhancing the manufacturing capabilities needed to produce high-quality,
affordable controlled release drugs.
Major companies
operating in the Vietnam Controlled Release Drug Delivery Market are:
- Merck Vietnam Co., Ltd
- JNTL Consumer Health (Vietnam) Co. Ltd.
- Pfizer (Vietnam) Limited Company
- AstraZeneca Vietnam Co., Ltd.
- Croda Vietnam
- DSM Nutritional Products Vietnam Ltd
- Evonik Vietnam LLC
- B. Braun Vietnam Co., Ltd.
- DHG Pharmaceutical Joint Stock Company
- Mekophar Chemical and Pharmaceutical JSC
Download Free Sample Report
Customers can
also request 10% free customization on this report
“The future of
the Vietnam Controlled Release Drug Delivery Market looks promising, driven by
increasing healthcare needs, advancements in pharmaceutical technology, and a
rising prevalence of chronic diseases. As the demand for more efficient and
convenient drug delivery systems grows, controlled release formulations will
become integral in chronic disease management, improving patient adherence and
treatment outcomes. With a growing middle class and improved healthcare
infrastructure, particularly in urban areas like Ho Chi Minh City and Hanoi,
the adoption of these systems will continue to expand. Pharmaceutical companies
are expected to invest more in research and development to enhance the
performance and affordability of controlled release drugs. The government’s
focus on healthcare development will further stimulate market growth. Overall,
the market is poised for steady growth as healthcare providers increasingly
integrate advanced drug delivery technologies into treatment regimens.,” said
Mr. Karan Chechi, Research Director, TechSci Research, a research-based
management consulting firm.
“Vietnam
Controlled Release Drug Delivery Market
By Technology (Wurster
Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery,
Others), By Release Mechanism (Polymer Based Systems, Micro Reservoir Partition
Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems,
Activation-modulated Drug Delivery Systems, Chemically Activated), By Delivery
Application (Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches,
Infusion Pumps, Oral Controlled-drug delivery Systems, and Drug Eluting Stents),
By
Region, Competition, Forecast and
Opportunities, 2020-2030F”, has evaluated
the future growth potential of Vietnam Controlled Release Drug Delivery Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision-makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Vietnam Controlled Release Drug Delivery
Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com